Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma

Table 1

Baseline characteristics of 87 patients diagnosed with mesothelioma.

Variables	Total patients ()
Age ()
Follow-up time (days)
Median (range)	527.00 (20-2790)
Gender
Female	16 (18.39%)
Male	71 (81.61%)
Race
Asian	1 (1.15%)
Black or African American	1 (1.15%)
White	85 (97.70%)
State
Alive	12 (13.79%)
Dead	73 (83.91%)
Unknown	2 (2.30%)
Distant metastasis
Yes	26 (29.89%)
No	61 (70.11%)
Bone metastasis
Yes	4 (4.60%)
No	83 (95.40%)
Stage
Stage I	10 (11.49%)
Stage II	16 (18.39%)
Stage III	45 (51.72)
Stage IV	16 (18.39%)
AJCC-T
T1	14 (16.09%)
T2	26 (29.89%)
T3	32 (36.78%)
T4	13 (14.94%)
TX	2 (2.30%)
AJCC-N
N0	44 (50.57%)
N1	10 (11.49%)
N2	26 (29.89%)
N3	3 (3.45%)
NX	4 (4.60%)
AJCC-M
M0	57 (65.52%)
M1	3 (3.45%)
MX	27 (31.03%)

Abbreviation: AJCC: American Joint Committee on Cancer.